Azoles

19,143views

Azoles

BIIC

BIIC

Microcytic anemia: Pathology review
Macrocytic anemia: Pathology review
Anemia: Clinical
Iron deficiency anemia
Non-hemolytic normocytic anemia: Pathology review
Anemia of chronic disease
Aplastic anemia
Sideroblastic anemia
Fanconi anemia
Megaloblastic anemia
Autoimmune hemolytic anemia
Diamond-Blackfan anemia
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Alpha-thalassemia
Beta-thalassemia
Malabsorption syndromes: Pathology review
Blood histology
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Role of Vitamin K in coagulation
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Plasma cell disorders: Pathology review
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Warfarin
Thrombolytics
Antiplatelet medications
Hematopoietic medications
Ribonucleotide reductase inhibitors
Microtubule inhibitors
Monoclonal antibodies
DNA alkylating medications
Antimetabolites for cancer treatment
Thymus histology
Lymph node histology
Spleen histology
Sepsis
Hemolytic disease of the newborn
Graves disease
DiGeorge syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate kinase deficiency
Sickle cell disease (NORD)
Paroxysmal nocturnal hemoglobinuria
Hereditary spherocytosis
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Hemophilia
Vitamin K deficiency
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Immune thrombocytopenia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Heparin-induced thrombocytopenia
Disseminated intravascular coagulation
Antithrombin III deficiency
Protein C deficiency
Antiphospholipid syndrome
Factor V Leiden
Protein S deficiency
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Leukemoid reaction
Myelodysplastic syndromes
Polycythemia vera (NORD)
Essential thrombocythemia (NORD)
Myelofibrosis (NORD)
Multiple myeloma
Waldenstrom macroglobulinemia
Monoclonal gammopathy of undetermined significance
Bacillus anthracis (Anthrax)
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Pseudomonas aeruginosa
Yersinia enterocolitica
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Yersinia pestis (Plague)
Francisella tularensis (Tularemia)
Brucella
Pasteurella multocida
Borrelia burgdorferi (Lyme disease)
Leptospira
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Coxiella burnetii (Q fever)
Cytomegalovirus
Epstein-Barr virus (Infectious mononucleosis)
Human herpesvirus 8 (Kaposi sarcoma)
Yellow fever virus
Dengue virus
West Nile virus
HIV (AIDS)
Hantavirus
Candida
Pneumocystis jirovecii (Pneumocystis pneumonia)
Cryptococcus neoformans
Babesia
Plasmodium species (Malaria)
Cryptosporidium
Toxoplasma gondii (Toxoplasmosis)
Trypanosoma brucei
Trypanosoma cruzi (Chagas disease)
Leishmania
Trichomonas vaginalis
Antimetabolites: Sulfonamides and trimethoprim
Protein synthesis inhibitors: Aminoglycosides
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Herpesvirus medications
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Azoles
Antimalarials

Transcript

Watch video only

The “azole” antifungals are a family of medications used to treat mycoses, or fungal infections.

Mycoses can be superficial, like on the skin or hair, or develop into systemic infections in immunodeficient people.

Antifungals work either through fungistatic action, meaning that they inhibit fungal growth, or through fungicidal action, meaning they kill the fungi.

Azoles are divided into two major families of antifungals: imidazoles and triazoles.

Most fungal cells have a tough outer cell wall and an inner cell membrane.

The cell membrane is mostly made of phospholipids with some sterol or modified steroid molecules mixed in.

Humans have cholesterol, while fungi have ergosterol.

Both sterol molecules help keep the cell membrane stable at a wide range of temperatures.

Now, the precursor to both molecules is lanosterol.

Fungi have a cytochrome p450 enzyme called fourteen-alpha-demethylase in their mitochondria and endoplasmic reticulums, which converts lanosterol to ergosterol.

Without ergosterol, the structure of the cell membrane will be disrupted.

This will cause membrane-bound proteins, like ion channels, to stop working properly.

The membrane also becomes fragile, which eventually leads to inhibition of fungal growth.

The azole antifungals include imidazoles, like clotrimazole, isoconazole, miconazole, butoconazole, fenticonazole, and ketoconazole; as well as triazoles like fluconazole, itraconazole and voriconazole.

The only difference between the two groups is the imidazoles contain an imidazole ring, while triazoles contain triazole rings.

These medications work by inhibiting the fourteen-alpha-demethylase enzyme.

However, they also inhibit human cytochrome P450 enzymes to a lesser degree.

Because of this, the vast majority of azoles come in topical form, and they’re commonly used to treat superficial mycoses.

Azole creams are used for treating dermatophytosis, or ringworm, which is a red, itchy, scaly, circular rash, on the feet, groin, or armpit area, caused by Trichophyton fungus.

These fungi are also responsible for the more common “athlete’s foot” or “jock itch”.

Additionally, azoles can be used to treat tinea versicolor, caused by Malassezia globosa.

This disease is characterized by hypopigmentation or hyperpigmentation in patches of skin.

Last but not least, topical azoles are also used to treat yeast infections, such as oral or vaginal candidiasis caused by Candida species.

Topical use of azole antifungals is generally considered to be safe, since absorption through the skin is minimal, and the most common side effect is skin irritation.

Key Takeaways

Azoles are synthetic antifungals with broad spectrum activity against various fungal infections. Azoles bind to the ergosterol molecule in the fungal cell membrane and cause holes to form, which damages the cell membrane and eventually kills the fungus. Examples of azoles include drugs like clotrimazole, fluconazole, and itraconazole. Some of the side effects of azoles include nausea and vomiting, gynecomastia, and hepatotoxicity.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Therapeutic tools for oral candidiasis: Current and new antifungal drugs" Medicina Oral Patología Oral y Cirugia Bucal (2019)
  5. "Adverse interactions between antifungal azoles and vincristine: review and analysis of cases" Mycoses (2011)